Health initiatives

Nightingale’s health data platform offers novel scientific opportunities for large-scale health initiatives. Comprehensive health results can be given to both scientists and participants to advance research and personal health.

Analysing half a million samples from UK Biobank

Nightingale is analysing the biomarker profiles of 500,000 blood samples from the UK Biobank, the world's largest health database. The comprehensive metabolic biomarker profiles will be analysed in 30 months to facilitate global medical research a wealth of scientific applications.

GLOBAL COLLABORATIONS

Nightingale and Estonian Biobank Agree Strategic Collaboration Aiming to Work Towards Estonian Biobank’s Nationwide Early Disease Prevention in Estonia

February 4, 2021

Nightingale and Imperial College London to investigate new indicators of diabetes in the South Asian population

November 4, 2019

Nightingale collaborates with National University of Singapore to realise the prevention of chronic diseases in South East Asia

Nightingale to analyse the world’s largest blood-based prospective cohort study in Latin America

September 4, 2018

Nightingale and THL Biobank to analyze 40,000 blood samples

Pioneering China Kadoorie Biobank study uses Nightingale technology

February 14, 2018

World-leading publications

For individuals

Blood test and app

For business

Nightingale for business

Health initiatives

For investors

Nightingale as an investment

Financial information

Share and shareholders

Investor relations

Reports and presentations

For research

Blood Biomarker Analysis

About us

Get our newsletter

Interested in getting the latest news about Nightingale? Subscribe to our newsletter.

Nightingale Health Oyj

Mannerheimintie 164a, 00300 Helsinki, Finland

© 2020 Nightingale HealthTerms and policies